|From: hickin (Rep: 56)||Date: 12/16/2011 08:15|
|Forum: ISTA Pharmaceuticals - Msg #90||Thread #673335792 (Rec: 0) |
|7:32AM ISTA Pharm: Valeant Pharmaceuticals (VRX) proposes to acquire ISTA Pharmaceuticals for $6.50 per share in cash (ISTA) 3.89 : Valeant Pharmaceuticals International (VRX) announced that it had made a proposal to the Board ISTA Pharmaceuticals (ISTA) to acquire ISTA for $6.50 per share in cash. The proposed transaction has a total equity value of ~$314 mln on a fully diluted basis. In addition, ISTA has net debt of ~$13 mln, bringing the total enterprise value to ~$327 mln. This proposed price represents a premium of ~67% over ISTA's closing price of $3.89 on December 15, 2011.|
TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.